How we treat metastatic renal cell carcinoma: Options beyond first-line therapy
Last Updated: Thursday, December 21, 2023
This review uses data from retrospective cohorts and prospective studies investigating post-frontline therapy options for patients with mRCC and shares practical considerations to aid oncology practitioners in optimizing therapy selection in the second-line setting.
Advertisement
News & Literature Highlights